Case–control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population

[1]  John P A Ioannidis,et al.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database , 2008, Nature Genetics.

[2]  L. Abramova,et al.  Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population , 2008, Schizophrenia Research.

[3]  Jürgen Gallinat,et al.  Molecular Mechanisms of Schizophrenia , 2007, Cellular Physiology and Biochemistry.

[4]  J. Hoenicka,et al.  C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients , 2006, Acta psychiatrica Scandinavica.

[5]  Jarmo Hietala,et al.  Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophrenia , 2006, Neuroscience Letters.

[6]  Nathaniel G. Hurwitz,et al.  Schizoaffective disorders are psychotic mood disorders; there are no schizoaffective disorders , 2006, Psychiatry Research.

[7]  D. Collier,et al.  Evaluation of a Susceptibility Gene for Schizophrenia: Genotype Based Meta-Analysis of RGS4 Polymorphisms from Thirteen Independent Samples , 2006, Biological Psychiatry.

[8]  Brien Riley,et al.  Molecular genetic studies of schizophrenia , 2006, European Journal of Human Genetics.

[9]  E. Jönsson,et al.  The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: Evidence from fixed‐ and random‐effects meta‐analyses , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[10]  Samir K. Brahmachari,et al.  Association of DRD2 gene variant with schizophrenia , 2006, Neuroscience Letters.

[11]  Á. Carracedo,et al.  Relative efficiency of the linkage disequilibrium mapping approach in detecting candidate genes for schizophrenia in different European populations. , 2005, Genomics.

[12]  A. Addington,et al.  The neurodevelopmental model of schizophrenia: update 2005 , 2005, Molecular Psychiatry.

[13]  S. Faraone,et al.  Five NOTCH4 polymorphisms show weak evidence for association with schizophrenia: evidence from meta-analyses , 2005, Schizophrenia Research.

[14]  C. P. Morris,et al.  The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia , 2005, Schizophrenia Research.

[15]  J. Lieberman,et al.  Amphetamine-Induced Fos is Reduced in Limbic Cortical Regions but not in the Caudate or Accumbens in a Genetic Model of NMDA Receptor Hypofunction , 2004, Neuropsychopharmacology.

[16]  K. Någren,et al.  C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo , 2004, Molecular Psychiatry.

[17]  S. Faraone,et al.  DRD2 −141C insertion/deletion polymorphism is not associated with schizophrenia: Results of a meta‐analysis , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[18]  M. Neville,et al.  Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1 , 2004, Human mutation.

[19]  Laurent Gouya,et al.  The 3′ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia , 2004, Schizophrenia Research.

[20]  M C O'Donovan,et al.  The molecular genetics of schizophrenia: new findings promise new insights , 2004, Molecular Psychiatry.

[21]  S. Faraone,et al.  Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia , 2003, Molecular Psychiatry.

[22]  Paul J. Harrison,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Genes for Schizophrenia? Recent Findings and Their Pathophysiological Implications , 2022 .

[23]  N. Saitou,et al.  Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. , 2003, Human molecular genetics.

[24]  I. Gottesman,et al.  The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia , 2002, BMC psychiatry.

[25]  Yusuke Nakamura,et al.  A high-throughput SNP typing system for genome-wide association studies , 2001, Journal of Human Genetics.

[26]  Alessandro Usiello,et al.  Distinct functions of the two isoforms of dopamine D2 receptors , 2000, Nature.

[27]  K. Otani,et al.  Association between Taq1 a dopamine D2 receptor polymorphism and psychopathology of schizophrenia in Japanese patients , 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[28]  S. Kapur,et al.  Schizophrenia: more dopamine, more D2 receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Kevin T. Hansen,et al.  Dopamine D2 densities and the schizophrenic brain , 1998, Schizophrenia Research.

[30]  J. Thome,et al.  Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses , 1998, Journal of Neural Transmission.

[31]  T. Arinami,et al.  A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. , 1997, Human molecular genetics.

[32]  J. Nobrega,et al.  Dopamine D2‐like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinoline , 1997, Synapse.

[33]  D. Sibley,et al.  Functional Analysis of the Human D2 Dopamine Receptor Missense Variants* , 1996, The Journal of Biological Chemistry.

[34]  M. Itokawa,et al.  Association of dopamine D2 receptor molecular variant with schizophrenia , 1994, The Lancet.

[35]  P. Seeman,et al.  Dopamine receptor pharmacology. , 1994, Trends in pharmacological sciences.

[36]  M. Itokawa,et al.  A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys). , 1993, Biochemical and biophysical research communications.

[37]  D. Sibley,et al.  Molecular biology of dopamine receptors. , 1992, Trends in pharmacological sciences.